Tyra Biosciences Inc (TYRA)
16.22
+0.47
(+2.98%)
USD |
NASDAQ |
May 31, 16:00
16.27
+0.05
(+0.31%)
After-Hours: 20:00
Tyra Biosciences Enterprise Value: 469.73M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 469.73M |
| May 30, 2024 | 445.04M |
| May 29, 2024 | 455.02M |
| May 28, 2024 | 480.77M |
| May 24, 2024 | 527.53M |
| May 23, 2024 | 510.71M |
| May 22, 2024 | 546.97M |
| May 21, 2024 | 586.90M |
| May 20, 2024 | 601.08M |
| May 17, 2024 | 576.91M |
| May 16, 2024 | 621.05M |
| May 15, 2024 | 586.37M |
| May 14, 2024 | 593.73M |
| May 13, 2024 | 589.52M |
| May 10, 2024 | 529.10M |
| May 09, 2024 | 550.64M |
| May 08, 2024 | 564.83M |
| May 07, 2024 | 559.82M |
| May 06, 2024 | 581.35M |
| May 03, 2024 | 555.09M |
| May 02, 2024 | 590.81M |
| May 01, 2024 | 578.20M |
| April 30, 2024 | 515.70M |
| April 29, 2024 | 481.56M |
| April 26, 2024 | 440.59M |
| Date | Value |
|---|---|
| April 25, 2024 | 411.17M |
| April 24, 2024 | 457.92M |
| April 23, 2024 | 477.88M |
| April 22, 2024 | 431.66M |
| April 19, 2024 | 404.35M |
| April 18, 2024 | 387.54M |
| April 17, 2024 | 376.51M |
| April 16, 2024 | 387.80M |
| April 15, 2024 | 392.27M |
| April 12, 2024 | 399.62M |
| April 11, 2024 | 409.07M |
| April 10, 2024 | 423.25M |
| April 09, 2024 | 513.07M |
| April 08, 2024 | 515.70M |
| April 05, 2024 | 562.97M |
| April 04, 2024 | 562.97M |
| April 03, 2024 | 541.09M |
| April 02, 2024 | 498.06M |
| April 01, 2024 | 503.31M |
| March 28, 2024 | 657.88M |
| March 27, 2024 | 652.62M |
| March 26, 2024 | 644.75M |
| March 25, 2024 | 661.55M |
| March 22, 2024 | 674.68M |
| March 21, 2024 | 675.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-72.83M
Minimum
Jun 17 2022
980.86M
Maximum
Nov 04 2021
306.55M
Average
310.51M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.19M |
| Total Expenses (Quarterly) | 22.32M |
| EPS Diluted (Quarterly) | -0.35 |
| Earnings Yield | -10.36% |